129 related articles for article (PubMed ID: 29864111)
1. Prognostic Value of Dynactin mRNA Expression in Cutaneous Melanoma.
Wang Q; Wang X; Liang Q; Wang S; Liao X; Li D; Pan F
Med Sci Monit; 2018 Jun; 24():3752-3763. PubMed ID: 29864111
[TBL] [Abstract][Full Text] [Related]
2. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
Su X; Li H; Chen S; Qin C
Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
[TBL] [Abstract][Full Text] [Related]
3. Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma.
Wang S; Wang Q; Zhang X; Liao X; Wang G; Yu L; Zhang W; Zhou Q; Hu S; Yuan W
Cancer Manag Res; 2018; 10():5807-5824. PubMed ID: 30510450
[TBL] [Abstract][Full Text] [Related]
4. A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.
Guo W; Zhu L; Zhu R; Chen Q; Wang Q; Chen JQ
Elife; 2019 Jun; 8():. PubMed ID: 31169496
[TBL] [Abstract][Full Text] [Related]
5. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Liu X; Wang J
Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
[TBL] [Abstract][Full Text] [Related]
6. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
7. A novel inflammatory response-related signature predicts the prognosis of cutaneous melanoma and the effect of antitumor drugs.
Xing J; Li Y; Chen Y; Han Y
World J Surg Oncol; 2022 Aug; 20(1):263. PubMed ID: 35982458
[TBL] [Abstract][Full Text] [Related]
8. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
9. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
12. Aberrant NEK2 expression might be an independent predictor for poor recurrence-free survival and overall survival of skin cutaneous melanoma.
Huang J; Sun SG; Hou S
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3694-3702. PubMed ID: 29949142
[TBL] [Abstract][Full Text] [Related]
13. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma.
Wan X; Liu R; Li Z
Biomed Res Int; 2017; 2017():5356737. PubMed ID: 29349077
[TBL] [Abstract][Full Text] [Related]
15. 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.
Bailey CN; Martin BJ; Petkov VI; Schussler NC; Stevens JL; Bentler S; Cress RD; Doherty JA; Durbin EB; Gomez SL; Gonsalves L; Hernandez BY; Liu L; Morawski BM; Schymura MJ; Schwartz SM; Ward KC; Wiggins C; Wu XC; Goldberg MS; Siegel JJ; Cook RW; Covington KR; Kurley SJ
JCO Precis Oncol; 2023 Jun; 7():e2300044. PubMed ID: 37384864
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
17. The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Vogelsang M; Martinez CN; Rendleman J; Bapodra A; Malecek K; Romanchuk A; Kazlow E; Shapiro RL; Berman RS; Krogsgaard M; Osman I; Kirchhoff T
Clin Cancer Res; 2016 Jul; 22(13):3268-80. PubMed ID: 26733611
[TBL] [Abstract][Full Text] [Related]
18. L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma.
Song J; Jin C; Chen E; Dong X; Zhu L
Biomed Res Int; 2021; 2021():6648182. PubMed ID: 33829062
[TBL] [Abstract][Full Text] [Related]
19. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
Yang S; Xu J; Zeng X
Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
[TBL] [Abstract][Full Text] [Related]
20. XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.
Gomez GV; de Oliveira C; Rinck-Junior JA; de Moraes AM; Lourenço GJ; Lima CS
Tumour Biol; 2016 Mar; 37(3):3163-71. PubMed ID: 26427666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
